journal
https://read.qxmd.com/read/37246116/myelin-oligodendrocyte-glycoprotein-antibody-associated-disease-in-a-patient-with-symptoms-of-aseptic-meningitis-who-achieved-spontaneous-remission-a-case-report-and-review-of-the-literature
#41
REVIEW
Naomi Hino-Fukuyo, Eiichiro Kawai, Sakiko Itoh, Shuhei Oba, Yukie Sato, Sei Abe, Yukari Ichikawa, Hiroshi Kitazawa, Yuri Atobe, Juichi Fujimori, Ichiro Nakashima, Toshiyuki Takahashi, Tetsuji Morimoto
BACKGROUND: A few case reports have described patients with myelin oligodendrocyte glycoprotein antibody (MOG-Ab)-associated demyelinating syndrome who presented with symptoms of aseptic meningitis. All such patients required immunotherapy. We report a patient with MOG-Ab-associated disorder (MOGAD) who presented with symptoms of aseptic meningitis and improved without treatment. CASE: A 13-year-old girl presented with fever, headache, decreased appetite, and neck stiffness...
September 2023: Brain & Development
https://read.qxmd.com/read/37657961/later-efficacy-of-nusinersen-treatment-in-adult-patients-with-spinal-muscular-atrophy-a-retrospective-case-study-with-a-median-4-year-follow-up
#42
Michinori Funato, Atsunari Kino, Reina Iwata, Misaki Yumioka, Kohei Yamashita, Chika Urui, Ryoya Uno, Emi Kondo, Etsuko Morioka, Yoko Ogawa, Akihisa Kawamura, Toshifumi Kusukawa, Hiroshi Minatsu
BACKGROUND: Spinal muscular atrophy (SMA) is a hereditary neuromuscular disorder characterized by skeletal muscle atrophy and weakness. New treatments for SMA have been developed namely, the drugs nusinersen, onasemnogene abeparvovec, and risdiplam. However, there are limited reports on their effects on adult patients with SMA, particularly over long periods. Therefore, this study aimed to determine the efficacy of nusinersen treatment in adult patients with SMA. METHODS: We retrospectively reviewed patients with SMA type 2 or 3 who received nusinersen treatment between January 2018 and January 2023...
August 30, 2023: Brain & Development
https://read.qxmd.com/read/37661525/severe-and-rare-neurological-manifestations-following-covid-19-infection-in-children-a-malaysian-tertiary-centre-experience
#43
JOURNAL ARTICLE
Muhamad Azamin Anuar, Jun Xiong Lee, Husna Musa, Dianah Abd Hadi, Elyssa Majawit, Poorani Anandakrishnan, Sumitha Murugesu, Ahmad Rithauddin Mohamed, Teik Beng Khoo
INTRODUCTION: Since the emergence of COVID-19, we have experienced potent variants and sub-variants of the virus with non-specific neurological manifestations. We observed a surge of the Omicron variant of COVID-19 patients with neurological manifestations where less cases of multisystem inflammatory syndrome in children (MIS-C) were reported. This article describes our experience of children with severe and rare neurological manifestations following COVID-19 infection. METHODS: This is a retrospective observational case series of patients under 18 years old who fulfilled the WHO COVID-19 case definition and were referred to our paediatric neurology unit at Hospital Tunku Azizah Kuala Lumpur...
August 29, 2023: Brain & Development
https://read.qxmd.com/read/37648626/the-gaze-characteristics-in-preterm-children-the-appropriate-timing-for-an-eye-tracking-tool
#44
JOURNAL ARTICLE
Soichi Yamase, Wakako Ishii, Nobuhiko Nagano, Aya Okahashi, Kimiko Deguchi, Emiko Momoki, Ichiro Morioka
BACKGROUND: An objective screening tool for autism spectrum disorder (ASD), also known as an eye-tracking tool, assesses the patient's abnormal gaze patterns and detects the risk of ASD. As this tool is generally used for children born at term, this study aimed to clarify the appropriate timing for using the tool for preterm children, factors that influence the timing, and evaluate their gaze characteristics using the Gazefinder®. METHOD: In 90 preterm children, a total of 125 eye-tracking tasks were completed and analyzed in 3-6, 7-9, 10-12, 13-18, and 19-32 months of corrected age (CA)...
August 28, 2023: Brain & Development
https://read.qxmd.com/read/37634963/survey-of-medications-for-myelomeningocele-patients-over-their-lifetime-in-japan
#45
JOURNAL ARTICLE
Haruna Isozaki, Masahiro Nonaka, Yumiko Komori, Katsuya Ueno, Haruka Iwamura, Mayuko Miyata, Natsumi Yamamura, Yi Li, Junichi Takeda, Yuichiro Nonaka, Ichiro Yabe, Masayoshi Zaitsu, Kenji Nakashima, Akio Asai
BACKGROUND: This study aimed to investigate medication prescriptions for patients with myelomeningocele (MMC) across different age groups, particularly in adulthood and after middle age. METHODS: The Japan Medical Data Center (JMDC) database, based on medical claims data, was utilized for this analysis. Patients were divided into 10-year age groups, and prescriptions for analgesics, anticonvulsants, psychotropic drugs, lifestyle disease-related drugs, drugs for urinary incontinence, and laxatives were examined...
August 26, 2023: Brain & Development
https://read.qxmd.com/read/37633739/atp6v1b2-related-disorders-featuring-lennox-gastaut-syndrome-a-case-based-overview
#46
Greta Amore, Elisa Calì, Maria Spanò, Giorgia Ceravolo, Giuseppe Donato Mangano, Giovanna Scorrano, Stephanie Efthymiou, Vincenzo Salpietro, Henry Houlden, Gabriella Di Rosa
BACKGROUND: ATP6V1B2 (ATPase, H+ transporting, lysosomal VI subunit B, isoform 2) encodes for a subunit of a ubiquitous transmembrane lysosomal proton pump, implicated in the acidification of intracellular organelles and in several additional cellular functions. Variants in ATP6V1B2 have been related to a heterogeneous group of multisystemic disorders sometimes associated with variable neurological involvement. However, our knowledge of genotype-phenotype correlations and the neurological spectrum of ATP6V1B2-related disorders remain limited due to the few numbers of reported cases...
August 24, 2023: Brain & Development
https://read.qxmd.com/read/37599126/a-boy-with-a-progressive-neurologic-decline-harboring-two-coexisting-mutations-in-kmt2d-and-vps13d
#47
Yu-Ming Chang, Yu-Wen Pan, Yen-Yin Chou, Wen-Hao Yu, Meng-Che Tsai
INTRODUCTION: Kabuki syndrome (KS) and spinocerebellar ataxia (SCA) are both rare conditions with neurodevelopmental abnormalities. Approaching a patient with complex phenotypes and differentiating the role of mutations may be beneficial but challenging in predicting the disease prognosis. CASE PRESENTATION: A boy presented with progressive ataxia, developmental regression, and myoclonus since 4 years of age. Additional features included growth hormone deficiency, excessive body hair, dysmorphic facies, hypoparathyroidism, and bilateral sensorineural hearing impairment...
August 18, 2023: Brain & Development
https://read.qxmd.com/read/37543484/neurochemistry-evaluated-by-magnetic-resonance-spectroscopy-in-a-patient-with-fbxo28-related-developmental-and-epileptic-encephalopathy
#48
Kentaro Sano, Fuyuki Miya, Mitsuhiro Kato, Taku Omata, Jun-Ichi Takanashi
BACKGROUND: Mutations in the FBXO28 gene, which encodes FBXO28, one of the F-box protein family, may cause developmental and epileptic encephalopathy (DEE). FBXO28-related DEE is radiologically characterized by cerebral atrophy, delayed/abnormal myelination, and brain malformation; however, no neurochemical analyses have been reported. CASE REPORT: A female Japanese infant presented with severe psychomotor delay, epileptic spasms, and visual impairment. Whole-exome sequencing revealed a de novo variant of the FBXO28 gene, leading to the diagnosis of FBXO28-related DEE...
August 3, 2023: Brain & Development
https://read.qxmd.com/read/37541812/evaluation-of-the-neurofilament-light-chain-as-a-biomarker-in-children-with-spinal-muscular-atrophy-treated-with-nusinersen
#49
JOURNAL ARTICLE
Gigyo Seo, Saeyoon Kim, Jun Chul Byun, Soonhak Kwon, Yun Jeong Lee
BACKGROUND: This study aimed to evaluate the neurofilament light chain (NfL) as a biomarker for treatment responses in children with a broad spectrum of spinal muscular atrophy (SMA) under nusinersen treatment. METHOD: We measured NfL levels in serum (sNfL) and cerebrospinal fluid (cNfL) in nusinersen-treated patients with SMA and children without neurologic disorders. Correlations between cNfL and sNfL levels and motor function scores were analyzed. RESULTS: sNfL and cNfL levels were measured in eight patients with SMA (SMA type 1, n = 3; SMA type 2, n = 5)...
August 2, 2023: Brain & Development
https://read.qxmd.com/read/37080866/favorable-outcome-of-hematopoietic-stem-cell-transplantation-in-late-onset-krabbe-disease
#50
Akihiko Mitsutake, Takashi Matsukawa, Atsushi Iwata, Hiroyuki Ishiura, Jun Mitsui, Harushi Mori, Takashi Toya, Akira Honda, Mineo Kurokawa, Norio Sakai, Shoji Tsuji, Tatsushi Toda
BACKGROUND: Late-onset Krabbe disease is a disorder with autosomal recessive inheritance caused by a deficiency in galactocerebrosidase (GALC) activity. Its late-onset form usually shows slow disease progression with atypical symptoms including spastic paresis. The efficacy of hematopoietic stem cell transplantation (HSCT) in late-onset Krabbe disease has not been fully established. CASE REPORT: We describe the case of a patient with late-onset Krabbe disease showing progressive spastic paraparesis...
August 2023: Brain & Development
https://read.qxmd.com/read/36967317/treatment-of-severe-acute-necrotizing-encephalopathy-of-childhood-with-interleukin-6-receptor-blockade-in-the-first-24%C3%A2-h-as-add-on-immunotherapy-shows-favorable-long-term-outcome-at-2%C3%A2-years
#51
Patrick H Hosie, Carylyn Lim, Timothy R D Scott, Michael Cardamone, Michelle A Farrar, Catherine Frith, Peter I Andrews, Jason Pinner, Sekhar Pillai
BACKGROUND: Acute necrotizing encephalopathy (ANE) of childhood is a rare and devastating infection-associated acute encephalopathy. While there are no consensus treatments for ANE, recent case reports suggest a beneficial role for the use of tocilizumab, a recombinant humanized monoclonal antibody against the interleukin-6 (IL-6) receptor. The correlation of the timing of add-on tocilizumab in relation to long-term outcome has not been reported. METHODS: We report on the timing of administration of tocilizumab in two patients classified as high-risk using the ANE severity score (ANE-SS) with respect to the long-term outcome at 2 years...
August 2023: Brain & Development
https://read.qxmd.com/read/37516579/a-screening-method-for-visual-attention-disabilities-in-cerebral-palsy-with-periventricular-leukomalacia
#52
JOURNAL ARTICLE
Toshiyuki Shimizu, Yasushi Miura
PURPOSE: Patients with periventricular leukomalacia (PVL) have been reported to have a variety of complications; however, whether these involve impaired visual attention disabilities remains unclear. Therefore, this study aimed to investigate the presence or absence and degree of visual attention disabilities in patients with PVL and propose a screening test that would allow anyone to check for visual attention disabilities easily. METHODS: The study participants were 14 patients with PVL and seven controls with dyskinetic cerebral palsy...
July 27, 2023: Brain & Development
https://read.qxmd.com/read/37481443/pediatric-anti-neutral-glycosphingolipid-antibodies-positive-encephalomyeloradiculoneuropathy-presenting-with-prominent-brain-demyelination
#53
Satoru Ochiai, Itaru Hayakawa, Tatsuro Mutoh, Yuichi Abe
BACKGROUND: Encephalomyeloradiculoneuropathy (EMRN) is characterized by progressive neurological symptoms in the central and peripheral nervous systems. The autoantibodies against neutral sphingolipids are disease-specific antibodies against EMRN. Although adults with EMRN typically present with symptoms of peripheral nervous system involvement, the symptoms in pediatric patients are not well understood. CASE: A 4-year-old boy was admitted to our hospital on the 10th day of fever due to poor oral intake and hyponatremia...
July 20, 2023: Brain & Development
https://read.qxmd.com/read/37453880/atypical-clinical-course-in-two-patients-with-gnb1-variants-who-developed-acute-encephalopathy
#54
Megumi Tsuji, Azusa Ikeda, Yu Tsuyusaki, Mizue Iai, Kenji Kurosawa, Kenjiro Kosaki, Tomohide Goto
INTRODUCTION: Variants in the GNB1 gene, which encodes the β1 subunit of a trimeric G protein, can cause moderate to severe psychomotor retardation. Acute encephalopathies have also been observed in patients with central nervous system abnormalities; however, severe neurological sequelae have not previously been reported. CASE PRESENTATIONS: Patient 1 was a Japanese female with a de novo GNB1 variant (c.284 T > C). At 8 months old she contracted influenza A and developed generalized convulsions...
July 13, 2023: Brain & Development
https://read.qxmd.com/read/37451886/a-novel-pathogenic-compound-heterozygous-variant-in-c12orf57-gene-in-a-child-with-temtamy-syndrome-presenting-with-overlapping-phenotypic-features-of-kabuki-like-syndrome
#55
Gayatri Nerakh, Madhavi Vasikarla
BACKGROUND: Autism spectrum disorder is a major neurodevelopmental disorder. Temtamy syndrome is a rare syndromic intellectual developmental disorder that presents with global developmental delay, autism, seizures, and agenesis/dysgenesis of the corpus callosum. METHODS: We report a case of a male child who presented with global developmental delay, and autism. Additional clinical features in the child were prominent eyes, long palpebral fissures with eversion of lateral third of the lower eyelid, hypoplastic nipples, and persistent fetal fingertip pads...
July 12, 2023: Brain & Development
https://read.qxmd.com/read/37442734/neonatal-developmental-and-epileptic-encephalopathy-with-movement-disorders-and-arthrogryposis-a-case-report-with-a-novel-missense-variant-of-scn1a
#56
Yukimune Okubo, Moriei Shibuya, Haruhiko Nakamura, Aritomo Kawashima, Kaori Kodama, Wakaba Endo, Takehiko Inui, Noriko Togashi, Yu Aihara, Matsuyuki Shirota, Ryo Funayama, Tetsuya Niihori, Atsushi Fujita, Keiko Nakayama, Yoko Aoki, Naomichi Matsumoto, Shigeo Kure, Atsuo Kikuchi, Kazuhiro Haginoya
Variants of SCN1A represent the archetypal channelopathy associated with several epilepsy syndromes. The clinical phenotypes have recently expanded from Dravet syndrome. CASE REPORT: We present a female patient with the de novo SCN1A missense variant, c.5340G > A (p. Met1780Ile). The patient had various clinical features with neonatal onset SCN1A epileptic encephalopathy, arthrogryposis multiplex congenita, thoracic hypoplasia, thoracic scoliosis, and hyperekplexia. CONCLUSION: Our findings are compatible with neonatal developmental and epileptic encephalopathy with movement disorders and arthrogryposis; the most severe phenotype probably caused by gain-of-function variant of SCN1A...
July 11, 2023: Brain & Development
https://read.qxmd.com/read/37442733/reply-to-the-letter-regarding-investigation-of-prognostic-factors-for-hhv-6-7-associated-acute-encephalopathy
#57
LETTER
Yoshihiro Watanabe, Mao Odaka, Hirotaka Motoi, Yoshitaka Oyama, Kentaro Shiga, Shuichi Ito
No abstract text is available yet for this article.
July 11, 2023: Brain & Development
https://read.qxmd.com/read/37429811/neonatal-onset-of-niemann-pick-disease-type-c-in-a-patient-with-cholesterol-re-accumulation-in-the-transplanted-liver-and-inflammatory-bowel-disease
#58
Kiri Koshu, Kazuhiro Muramatsu, Tomomi Maru, Yoshie Kurokawa, Yoshitaka Mizobe, Hirokazu Yamagishi, Daisuke Matsubara, Koji Yokoyama, Eriko Jimbo, Hideki Kumagai, Yukihiro Sanada, Yasunaru Sakuma, Noriyoshi Fukushima, Aya Narita, Takanori Yamagata, Hitoshi Osaka
BACKGROUND: Niemann-Pick disease type C (NPC) is an autosomal recessive inherited and neurodegenerative disorder. Approximately 10% of NPC patients have acute liver failure and sometimes need liver transplantation (LT), and 7% reportedly develop inflammatory bowel disease (IBD). We report the case of a girl with NPC who had a re- accumulation of cholesterol in the transplanted liver and NPC-related IBD. CASE REPORT: The patient underwent living donor liver transplantation (LDLT) due to severe acute liver failure caused by an unknown etiology inherited from her father...
July 8, 2023: Brain & Development
https://read.qxmd.com/read/37357027/a-serial-analysis-of-serum-aspartate-aminotransferase-levels-in-patients-with-acute-encephalopathy-with-biphasic-seizures-and-late-reduced-diffusion-and-prolonged-febrile-seizure
#59
JOURNAL ARTICLE
Ayaka Kasai, Mitsuo Motobayashi, Makoto Nishioka, Tetsuhiro Fukuyama, Yuji Inaba
BACKGROUND: There are no established biomarkers for diagnosing acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) in the early acute phase, called "the 1st seizure phase". Based on our clinical experience, we hypothesized that serial examinations of blood levels of aspartate aminotransferase (AST) in children with febrile convulsive status epilepticus (FCSE) revealed higher levels in patients with AESD in the 1st seizure phase than in those with prolonged febrile seizures (PFs)...
June 23, 2023: Brain & Development
https://read.qxmd.com/read/37328336/regarding-investigation-of-prognostic-factors-for-hhv-6-7-associated-acute-encephalopathy
#60
LETTER
Magda Sara Wojtara
No abstract text is available yet for this article.
June 14, 2023: Brain & Development
journal
journal
27751
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.